Global In Vitro Fertilization (IVF) Market - Strategic Insights and Forecasts (2025-2030)

The global In Vitro Fertilization (IVF) market is forecasted to demonstrate significant growth, expanding at a CAGR of 13.3% from 2025 to 2030. It is projected to increase from a valuation of USD 26.8 billion in 2025 to reach USD 50.1 billion by 2030, driven by various strategic and demographic factors outlined in the report.

Key growth drivers include the rising prevalence of male infertility, an increasing median age of first-time mothers due to career prioritization and later marriages, and rising obesity and alcohol consumption. Additionally, growing awareness of infertility, accessibility of cutting-edge treatment options, and the critical global need for reproductive care, as highlighted by a WHO report on infertility prevalence, are significant market accelerators.

The rising popularity and integral role of sperm separation systems are significant market drivers, as these are essential in most assisted reproductive technologies (ART), including IVF, by providing purified samples for subsequent procedures. The market is further expanding due to companies' increased focus on creating innovative devices specifically for ART procedures utilized in fertility clinics and obstetrician-gynecologist practices.

A key demographic trend is the increasing median age of first-time mothers, resulting from women prioritizing careers, delaying marriages, and the effective use of contraceptives. This trend, combined with a global infertility rate affecting approximately 1 in 6 adults (17.5%) according to a WHO report, creates a critical need for reproductive care and boosts IVF market demand.

According to a WHO report cited in the study, approximately 1 in 6 adults globally, or 17.5% of the population, are infertile. This significant prevalence demonstrates a critical need to expand access to high-quality, reasonably priced reproductive care, directly fueling the demand and growth of the in vitro fertilization market.

Innovation is a crucial driver in the competitive landscape, with companies increasingly focusing on developing advanced devices for assisted reproductive technology (ART) procedures. These innovations, particularly in areas like sperm separation systems, are essential for fertility clinics and OB/GYN practices, influencing competitive dynamics and overall market expansion towards 2030.